Literature DB >> 11983207

Expression of BRCA1 and BRCA2 in different tumor cell lines with various growth status.

Cécile Vissac1, Monique Peffault De Latour, Yves Communal, Yves-Jean Bignon, Dominique J Bernard-Gallon.   

Abstract

BACKGROUND: BRCA1 and BRCA2 are breast cancer susceptibility genes. Recent studies suggest that BRCA1 interacts with a great variety of proteins, including BRCA2, cell-cycle regulators, transcriptional activators and repressors. We investigated the expression of both BRCA1 and BRCA2 during the progression of the cell cycle of human tumor cell lines from different origins (MCF7, MDA-MB231, PA1 and CCL221) in two growth status (60% and 100% of confluency).
METHODS: First, the growth status was characterized by determination of the cell cycle by flow cytometry analysis. At the same time, immunohistochemistry was performed to follow BRCA1 and BRCA2 protein expression and then, quantification of BRCA1 and BRCA2 transcripts was realized using real-time quantitative RT-PCR.
RESULTS: We reported in studied tumor cell lines with 60% of confluency by comparison with 100% of confluency, an increase in the BRCA1 and BRCA2 expression at the level of proteins and transcripts.
CONCLUSION: Therefore, the expression of both BRCA1 and BRCA2 genes at the protein and mRNA levels appear to be up-regulated after cell proliferation in human tumor cell lines from different origins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11983207     DOI: 10.1016/s0009-8981(02)00055-4

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  5 in total

1.  A misquoted mutation in exon16 of the BRCA2 gene.

Authors:  Agapi Kataki; Anastasia Derventzi; Ilias Gomatos; Manoussos M Konstadoulakis
Journal:  J Hum Genet       Date:  2006-01-25       Impact factor: 3.172

2.  Simultaneous delivery of olaparib and carboplatin in PEGylated liposomes imparts this drug combination hypersensitivity and selectivity for breast tumor cells.

Authors:  Vojtech Novohradsky; Juraj Zajac; Oldrich Vrana; Jana Kasparkova; Viktor Brabec
Journal:  Oncotarget       Date:  2018-06-19

3.  Is Lactate an Oncometabolite? Evidence Supporting a Role for Lactate in the Regulation of Transcriptional Activity of Cancer-Related Genes in MCF7 Breast Cancer Cells.

Authors:  Iñigo San-Millán; Colleen G Julian; Christopher Matarazzo; Janel Martinez; George A Brooks
Journal:  Front Oncol       Date:  2020-01-14       Impact factor: 6.244

4.  Coxsackievirus B3 Infection of Human iPSC Lines and Derived Primary Germ-Layer Cells Regarding Receptor Expression.

Authors:  Janik Böhnke; Sandra Pinkert; Maria Schmidt; Hans Binder; Nicole Christin Bilz; Matthias Jung; Uta Reibetanz; Antje Beling; Dan Rujescu; Claudia Claus
Journal:  Int J Mol Sci       Date:  2021-01-27       Impact factor: 5.923

5.  Comparative Proteomics of Activated THP-1 Cells Infected with Mycobacterium tuberculosis Identifies Putative Clearance Biomarkers for Tuberculosis Treatment.

Authors:  Benjawan Kaewseekhao; Vivek Naranbhai; Sittiruk Roytrakul; Wises Namwat; Atchara Paemanee; Viraphong Lulitanond; Angkana Chaiprasert; Kiatichai Faksri
Journal:  PLoS One       Date:  2015-07-27       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.